Circadian heart rate variability in patients with primary arterial hypertension

Władysława Kolasińska-Kloch1, Agata Furgała, Tomasz Banach

  • 1II Klinika Kardiologii Instytutu Kardiologii, Collegium Medicum Uniwersytet Jagielloński, Kraków.

Przeglad Lekarski
|March 14, 2003
PubMed

Insights

Antihypertensive treatment with angiotensin-converting enzyme inhibitors (ACEI) did not improve cardiac autonomic function in hypertensive patients. Long-term ACEI therapy did not alter circadian heart rate variability, suggesting persistent autonomic dysfunction.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Function
  • Hypertension Research

Background:

  • Autonomic nervous system (ANS) dysfunction is implicated in essential hypertension.
  • Limited data exists on the impact of antihypertensive treatments, specifically ACE inhibitors (ACEI), on cardiac ANS activity.

Purpose of the Study:

  • To evaluate changes in circadian heart rate variability (HRV) in primary hypertension patients treated with ACE inhibitors.
  • To assess the effect of enalapril on cardiac autonomic function over one year.

Main Methods:

  • Fourteen "dipper" hypertensive patients and 14 healthy controls underwent 24-hour ambulatory blood pressure and ECG monitoring.
  • Hypertensive patients were assessed before and after one year of enalapril treatment.
  • Circadian HRV analysis utilized Fast Fourier Transformation (FFT) for time and spectral domain parameters.

Main Results:

  • Healthy controls exhibited significant circadian fluctuations in sympathetic and parasympathetic activity, with increased night-time HRV parameters and a decreased night/day LF/HF ratio.
  • After one year of ACEI treatment, hypertensive patients showed significant increases in RMSSD, pNN50, TP, VLF, LF, and HF, with a non-significant increase in the night/day LF/HF ratio.
  • Daily HRV parameters improved with ACEI treatment (increased pNN50 and RMSSD, decreased LF/HF ratio), but night-time HRV parameters showed no significant changes.

Conclusions:

  • Reduced night-time vagal activity may contribute to essential hypertension pathogenesis.
  • ACEI treatment did not restore circadian cardiac autonomic function in hypertensive "dippers", despite blood pressure normalization.
  • Persistent circadian cardiac autonomic dysfunction is suggested in this patient subgroup even after long-term ACEI therapy.
Abstract

Related Concept Videos

Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...